Dr. Glen Fenton

Dr. Glen Fenton cares for pediatric patients who suffer from seizure disorders, and specializes in the interpretation of neurophysiology testing. Dr. Fenton incorporates the latest innovative technologies and techniques in his practice, including the use of cannabinoids for pharmacoresistant (drug resistant) epilepsy patients. Dr. Fenton is a professor of Child Neurology in the Department of Neurology at Saint Louis University School of Medicine. He is a member of the examination subcommittee of the American Academy of Neurology and is a reviewer for the United Council of Neurological Subspecialties. He also serves as a reviewer for the National Board of Medical Examiners.

His clinical expertise encompasses Seizures, Lennox-Gastaut Syndrome (LGS), Status Epilepticus, and Generalized Tonic-Clonic Seizure.

Dr. Fenton is board certified in American Board Of Psychiatry & Neurology , American Board Of Psychiatry & Neurology-Epilepsy , American Board Of Psychiatry & Neurology/Epilepsy , American Board Of Psychiatry & Neurology/Neurology With Special Qualification In Child Neurology , Drug Enforcement Administration , Missouri Dept Of Health/Narcotics&Dangerous Drugs , and Missouri State Board Of Registration. He is actively involved in clinical research, co-authoring 1 peer reviewed article.